{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:40:04Z","timestamp":1771047604596,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T00:00:00Z","timestamp":1457308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10286-016-0349-7","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T07:51:48Z","timestamp":1457337108000},"page":"171-180","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension"],"prefix":"10.1007","volume":"26","author":[{"given":"Ahmed","family":"Elgebaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassant","family":"Abdelazeim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Mattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Gadelkarim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rehab","family":"Salah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5363-6369","authenticated-orcid":false,"given":"Ahmed","family":"Negida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"349_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/BF02291236","volume":"6","author":"H Kaufmann","year":"1996","unstructured":"Kaufmann H (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy. Clin Auton Res 6:125\u2013126","journal-title":"Clin Auton Res"},{"key":"349_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB et al (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21:69\u201372","journal-title":"Clin Auton Res"},{"key":"349_CR3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMcp074189","volume":"358","author":"R Freeman","year":"2008","unstructured":"Freeman R (2008) Clinical practice. Neurogenic orthostatic hypotension. N Engl J Med 358:615\u2013624. doi: 10.1056\/NEJMcp074189","journal-title":"N Engl J Med"},{"key":"349_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/VHRM.S53983","volume":"10","author":"SH Isaacson","year":"2014","unstructured":"Isaacson SH, Skettini J (2014) Neurogenic orthostatic hypotension in Parkinson\u2019s disease: evaluation, management, and emerging role of droxidopa. Vasc Health Risk Manag 10:169","journal-title":"Vasc Health Risk Manag"},{"key":"349_CR5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02292768","volume":"11","author":"DR Horowitz","year":"2001","unstructured":"Horowitz DR, Kaufmann H (2001) Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure. Clin Auton Res 11:363\u2013367. doi: 10.1007\/BF02292768","journal-title":"Clin Auton Res"},{"key":"349_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/187152907780059029","volume":"7","author":"S Maule","year":"2007","unstructured":"Maule S, Papotti G, Naso D et al (2007) Orthostatic hypotension: evaluation and treatment. Cardiovasc Hematol Disord Drug Targets 7:63\u201370","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"349_CR7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM197702102960601","volume":"296","author":"MG Ziegler","year":"1977","unstructured":"Ziegler MG, Lake CR, Kopin IJ (1977) The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med 296:293\u2013297. doi: 10.1056\/NEJM197702102960601","journal-title":"N Engl J Med"},{"key":"349_CR8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/CIRCULATIONAHA.108.805887","volume":"119","author":"DS Goldstein","year":"2009","unstructured":"Goldstein DS, Sharabi Y (2009) Neurogenic orthostatic hypotension: a pathophysiological approach. Circulation 119:139\u2013146","journal-title":"Circulation"},{"key":"349_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9343(99)00425-8","volume":"108","author":"WL Ooi","year":"2000","unstructured":"Ooi WL, Hossain M, Lipsitz LA (2000) The association between orthostatic hypotension and recurrent falls in nursing home residents. Am J Med 108:106\u2013111. doi: 10.1016\/S0002-9343(99)00425-8","journal-title":"Am J Med"},{"key":"349_CR10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1474-4422(08)70088-7","volume":"7","author":"PA Low","year":"2008","unstructured":"Low PA, Singer W (2008) Management of neurogenic orthostatic hypotension: an update. Lancet Neurol 7:451\u2013458","journal-title":"Lancet Neurol"},{"key":"349_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1146\/annurev.med.50.1.317","volume":"50","author":"CJ Mathias","year":"1999","unstructured":"Mathias CJ, Kimber JR (1999) Postural hypotension: causes, clinical features, investigation, and management. Annu Rev Med 50:317\u2013336","journal-title":"Annu Rev Med"},{"key":"349_CR12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1212\/WNL.38.6.951","volume":"38","author":"H Kaufmann","year":"1988","unstructured":"Kaufmann H, Brannan T, Krakoff L et al (1988) Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 38:951\u2013956","journal-title":"Neurology"},{"key":"349_CR13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2165\/00003495-198938050-00004","volume":"38","author":"D McTavish","year":"1989","unstructured":"McTavish D, Goa KL (1989) Midodrine. Drugs 38:757\u2013777","journal-title":"Drugs"},{"key":"349_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","volume":"95","author":"J Jankovic","year":"1993","unstructured":"Jankovic J, Gilden JL, Hiner BC et al (1993) Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 95:38\u201348. doi: 10.1016\/0002-9343(93)90230-M","journal-title":"Am J Med"},{"key":"349_CR15","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1001\/jama.1997.03540370036033","volume":"277","author":"PA Low","year":"1997","unstructured":"Low PA, Gilden JL, Freeman R et al (1997) Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA 277:1046\u20131051. doi: 10.1001\/jama.277.13.1046","journal-title":"JAMA"},{"key":"349_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/WNL.51.1.120","volume":"51","author":"R Wright","year":"1998","unstructured":"Wright R, Kaufmann H, Perera R et al (1998) A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension. Neurology 51:120\u2013124. doi: 10.1212\/WNL.51.1.120","journal-title":"Neurology"},{"key":"349_CR17","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0140-6736(87)91317-1","volume":"2","author":"I Biaggioni","year":"1987","unstructured":"Biaggioni I, Robertson D (1987) Endogenous restoration of noradrenaline by precursor therapy in dopamine-beta-hydroxylase deficiency. Lancet 2:1170\u20131172. doi: 10.1016\/S0140-6736(87)91317-1","journal-title":"Lancet"},{"key":"349_CR18","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1212\/WNL.53.9.2151","volume":"53","author":"R Freeman","year":"1999","unstructured":"Freeman R, Landsberg L, Young J (1999) The treatment of neurogenic orthostatic hypotension with 3,4-dl-threo-dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 53:2151\u20132157. doi: 10.1212\/WNL.53.9.2151","journal-title":"Neurology"},{"key":"349_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF02298955","volume":"11","author":"CJ Mathias","year":"2001","unstructured":"Mathias CJ, Senard JM, Braune S et al (2001) L-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 11:235\u2013242. doi: 10.1007\/BF02298955","journal-title":"Clin Auton Res"},{"key":"349_CR20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.0000083721.49847.D7","volume":"108","author":"H Kaufmann","year":"2003","unstructured":"Kaufmann H, Saadia D, Voustianiouk A et al (2003) Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 108:724\u2013728. doi: 10.1161\/01.CIR.0000083721.49847.D7","journal-title":"Circulation"},{"key":"349_CR21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1212\/WNL.0000000000000615","volume":"83","author":"H Kaufmann","year":"2014","unstructured":"Kaufmann H, Freeman R, Biaggioni I et al (2014) Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology 83:328\u2013335. doi: 10.1212\/WNL.0000000000000615","journal-title":"Neurology"},{"key":"349_CR22","first-page":"1","volume":"00","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Isaacson S, Lisk JP et al (2014) Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B). Neurology 00:1\u20139. doi: 10.1002\/mds.26086","journal-title":"Neurology"},{"key":"349_CR23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/HYPERTENSIONAHA.114.04035","volume":"65","author":"I Biaggioni","year":"2015","unstructured":"Biaggioni I, Freeman R, Mathias CJ et al (2015) Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopa. Hypertension 65:101\u2013107. doi: 10.1161\/HYPERTENSIONAHA.114.04035","journal-title":"Hypertension"},{"key":"349_CR24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","volume":"4","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S (2014) Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson\u2019s disease (NOH306A). J Parkinsons Dis 4:57\u201365. doi: 10.3233\/JPD-130259","journal-title":"J Parkinsons Dis"},{"key":"349_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10286-011-0146-2","volume":"22","author":"H Kaufmann","year":"2012","unstructured":"Kaufmann H, Malamut R, Norcliffe-Kaufmann L et al (2012) The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin Auton Res 22:79\u201390. doi: 10.1007\/s10286-011-0146-2","journal-title":"Clin Auton Res"},{"key":"349_CR26","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/bmj.331.7521.903","volume":"331","author":"DGG Altman","year":"2005","unstructured":"Altman DGG, Bland JMM (2005) Standard deviations and standard errors. BMJ 331:903. doi: 10.1136\/bmj.331.7521.903","journal-title":"BMJ"},{"key":"349_CR27","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634. doi: 10.1136\/bmj.316.7129.469","journal-title":"BMJ"},{"key":"349_CR28","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/sim.1461","volume":"22","author":"N Terrin","year":"2003","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I (2003) Adjusting for publication bias in the presence of heterogeneity. Stat Med 22:2113\u20132126. doi: 10.1002\/sim.1461","journal-title":"Stat Med"},{"key":"349_CR29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.0000000000000815","volume":"83","author":"A Izcovich","year":"2014","unstructured":"Izcovich A, Gonz\u00e1lez Malla C, Manzotti M et al (2014) Midodrine for orthostatic hypotension and recurrent reflex syncope: a systematic review. Neurology 83:1170\u20131177. doi: 10.1212\/WNL.0000000000000815","journal-title":"Neurology"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-016-0349-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10286-016-0349-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-016-0349-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T19:44:33Z","timestamp":1600285473000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10286-016-0349-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s10286-016-0349-7","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}